American Shared Hospital Services Announces Second Quarter Financial Results Conference Call
MWN-AI** Summary
American Shared Hospital Services (NYSE American: AMS), a prominent provider of stereotactic radiosurgery equipment and advanced radiation therapy for cancer treatment, has announced plans to hold a conference call to discuss its second quarter financial results for 2025. Scheduled for August 13 at 1:00 PM ET, the conference call will be preceded by the release of the company’s financial results, which will be published before the market opens that day.
For those wishing to participate in the call, domestic callers can dial 1-844-413-3972, while international participants can use 1-412-317-5776, with a recommendation to join at least 10 minutes prior to the start. Additionally, a webcast of the call will be available on the company’s website, providing another avenue for stakeholders to stay informed about AMS's performance.
American Shared Hospital Services specializes in providing comprehensive cancer treatment solutions to health systems across North and South America. The company collaborates with partners to enhance cancer service lines, making integrated care accessible to patients localized to their communities. Their operational model involves sharing capital investments and profits with health system partners, effectively distributing financial responsibilities based on ownership stakes.
A 'Safe Harbor Statement' included in the release indicates that forward-looking statements regarding the company's financial health and future strategies carry inherent risks and uncertainties. These can range from fluctuating market conditions to potential changes in reimbursement rates from the Centers for Medicare & Medicaid Services (CMS). The company has urged stakeholders to refer to its filings with the SEC for a more comprehensive understanding of risks impacting its business and financial outlook.
This proactive communication underlines AMS's commitment to transparency and investor relations, as it navigates the evolving landscape of healthcare services.
MWN-AI** Analysis
American Shared Hospital Services (AMS) is set to hold a conference call on August 13, 2025, to discuss its second-quarter financial results, an event that investors should strategically consider. As a leading provider of cancer treatment services and advanced radiation therapy equipment, AMS operates within a sector that can experience significant fluctuations based on healthcare trends, regulatory changes, and technological advancements.
Market stakeholders should prepare for potential volatility around the release of the financial results. Analysts will likely scrutinize revenue growth, profitability margins, and the company’s partnerships with health systems, as these factors influence the overall operational efficiency and future growth potential. Given AMS's reliance on capital investments shared with partners, monitoring cash flow and capital allocation from these partnerships will be critical.
Investors should particularly keep an eye on the company's forward-looking statements regarding growth in its Gamma Knife and proton therapy business lines. Expansions into new markets can present lucrative opportunities, but they also carry risks. Variability in quarterly financial results could indicate operational challenges and market conditions that investors need to evaluate critically.
Risks related to reimbursement rates and policy changes by the Center for Medicare and Medicaid Services (CMS) should not be overlooked, as they can substantially impact AMS's revenue model. Be mindful of the broader economic conditions impacting healthcare spending and patient volumes, as these factors will directly influence AMS's financial performance.
In advance of the call, it may be wise to assess existing positions or consider entering or exiting based on the company's guidance and expert insights. Following the results' announcement and subsequent analyst responses, adjusting portfolios could provide strategic advantages as the market responds to the company's outlook and performance.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
SAN FRANCISCO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its leasing and direct patient care services segments, today announced that the Company will hold a conference call to discuss its second quarter 2025 financial results on August 13 th at 1:00 pm ET.
The second quarter 2025 financial results press release will be issued before the market opens on August 13 th .
Teleconference and Webcast Information
To participate, domestic callers may dial 1-844-413-3972 and international callers may dial 1-412-317-5776 at least 10 minutes prior to the start of the call and ask to join the American Shared Hospital Services call.
A simultaneous webcast of the call may be accessed through the Company's website, www.ashs.com or directly:
https://event.choruscall.com/mediaframe/webcast.html?webcastid=uJ5x0Ugn
A replay of the call will be available at 1-877-344-7529 or 1-412-317-0088, access code 3350902, through August 20, 2025. The call will also be available for replay on the Company’s website at www.ashs.com .
About American Shared Hospital Services (NYSE American: AMS)
American Shared Hospital Services (AMS) is a leading provider of turnkey solutions to cancer treatment centers, health systems, and cancer networks in North and South America. The company works closely with its partners to develop and grow their cancer service lines and provide integrated cancer care to patients in a convenient local setting close to home. For centers under health system partnerships, the Company and its health system partners share in the capital investment cost and profitability of the operations based on their respective ownership interests. For more information, please visit: www.ashs.com .
Safe Harbor Statement
This press release may be deemed to contain certain forward-looking statements with respect to the financial condition, results of operations and future plans of American Shared Hospital Services including statements regarding the expected continued growth of the Company and the expansion of the Company’s Gamma Knife, proton therapy and advanced radiation therapy cancer treatment services businesses, which involve risks and uncertainties including, but not limited to, the risks of economic and market conditions, the risks of variability of financial results between quarters, the risks of the Gamma Knife, proton therapy and advanced radiation therapy cancer treatment services businesses, the risks of changes to CMS reimbursement rates or reimbursement methodology, the risks of the timing, financing, and operations of the Company’s Gamma Knife, proton therapy, and advanced radiation therapy cancer treatment services businesses, the risk of expanding within or into new markets, the risk that the integration or continued operation of acquired businesses could adversely affect financial results and the risk that current and future acquisitions may negatively affect the Company’s financial position. Further information on potential factors that could affect the financial condition, results of operations and future plans of American Shared Hospital Services is included in the filings of the Company with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for the year ended December 31, 2024.
Contacts:
American Shared Hospital Services
Ray Stachowiak, Executive Chairman and CEO
rstachowiak@ashs.com
Investor Relations
Kirin Smith, President
PCG Advisory, Inc.
ksmith@pcgadvisory.com
FAQ**
What key performance indicators will American Shared Hospital Services AMS highlight in their second quarter 2025 financial results report?
How does American Shared Hospital Services AMS plan to address the risks mentioned in their forward-looking statements during the upcoming conference call?
Can you provide insights into the expected growth of American Shared Hospital Services AMS in the context of the expanding markets for Gamma Knife and proton therapy services?
What strategies does American Shared Hospital Services AMS have in place to mitigate the risks associated with changes to CMS reimbursement rates in their operations?
**MWN-AI FAQ is based on asking OpenAI questions about American Shared Hospital Services (NYSE: AMS).
NASDAQ: AMS
AMS Trading
0.96% G/L:
$2.10 Last:
1,438 Volume:
$2.17 Open:



